February 21, 2008 / 12:41 PM / 10 years ago

QLT reports loss

TORONTO (Reuters) - QLT Inc QLT.TO reported a fourth-quarter loss on Thursday, hurt by slumping sales of its Visudyne anti-blindness treatment.

The company said it lost $46.5 million, or 62 cents a share, compared with a loss of $117.5 million, or $1.56 a share, a year earlier. The 2006 period included a charge of $112.5 million related to litigation at its U.S. subsidiary.

($1=$1.01 Canadian)

Reporting by Scott Anderson; editing by John Wallace

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below